Cargando…
Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
Research on cancer therapies focuses on processes such as angiogenesis, cell signaling, stemness, metastasis, and drug resistance and inflammation, all of which are influenced by the cellular and molecular microenvironment of the tumor. Different strategies, such as antibodies, small chemicals, horm...
Autores principales: | Albiñana, Virginia, Gallardo-Vara, Eunate, Casado-Vela, Juan, Recio-Poveda, Lucía, Botella, Luisa María, Cuesta, Angel M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369479/ https://www.ncbi.nlm.nih.gov/pubmed/35956154 http://dx.doi.org/10.3390/jcm11154539 |
Ejemplares similares
-
The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases
por: Cuesta, Angel M., et al.
Publicado: (2022) -
Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding
por: Albiñana, Virginia, et al.
Publicado: (2020) -
Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial
por: González-Rodríguez, Beatriz, et al.
Publicado: (2019) -
Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease
por: Albiñana, Virginia, et al.
Publicado: (2017) -
Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel–Lindau Disease
por: Albiñana, Virginia, et al.
Publicado: (2020)